Terug
56
46
68
Ook genoteerd als
ORRAF
OTC
Dagbereik
€ 9,46
€ 11,68
52-Weeksbereik
€ 8,14
€ 11,68
Volume
100
50D / 200D Gem.
€ 11,68
/
€ 10,21
Vorige Slotkoers
€ 11,68
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (609 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 1,9 | 11,1 |
| P/B | 0,6 | 1,4 |
| ROE % | 39,0 | 10,7 |
| Net Margin % | 46,6 | 5,1 |
| Rev Growth 5Y % | -12,3 | 8,3 |
| D/E | 0,2 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
2,3 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
2,2 B | 0 |
Belangrijkste Punten
Revenue declined -12,33% annually over 5 years
Earnings grew 425,43% over the past year
ROE of 39,02% indicates high profitability
Net margin of 46,56% shows strong profitability
Debt/Equity of 0,23 — conservative balance sheet
Generating 106,10M in free cash flow
Groei
Revenue Growth (5Y)
-12,33%
Revenue (1Y)-55,50%
Earnings (1Y)425,43%
FCF Growth (3Y)32,32%
Kwaliteit
Return on Equity
39,02%
ROIC1,84%
Net Margin46,56%
Op. Margin4,17%
Veiligheid
Debt / Equity
0,23
Current Ratio1,42
Interest Coverage1,21
Waardering
P/E Ratio
1,88
P/B Ratio0,63
EV/EBITDA25,47
Dividend Yield0,07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -55,50% | Revenue Growth (3Y) | -30,21% |
| Earnings Growth (1Y) | 425,43% | Earnings Growth (3Y) | 129,47% |
| Revenue Growth (5Y) | -12,33% | Earnings Growth (5Y) | 63,61% |
| Profitability | |||
| Revenue (TTM) | 2,09B | Net Income (TTM) | 973,10M |
| ROE | 39,02% | ROA | 20,07% |
| Gross Margin | 23,09% | Operating Margin | 4,17% |
| Net Margin | 46,56% | Free Cash Flow (TTM) | 106,10M |
| ROIC | 1,84% | FCF Growth (3Y) | 32,32% |
| Safety | |||
| Debt / Equity | 0,23 | Current Ratio | 1,42 |
| Interest Coverage | 1,21 | Dividend Yield | 0,07% |
| Valuation | |||
| P/E Ratio | 1,88 | P/B Ratio | 0,63 |
| P/S Ratio | 0,87 | PEG Ratio | 0,01 |
| EV/EBITDA | 25,47 | Dividend Yield | 0,07% |
| Market Cap | 1,83B | Enterprise Value | 2,22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,09B | 4,70B | 4,29B | 4,09B | 3,54B |
| Net Income | 973,10M | 185,20M | 184,80M | 184,70M | 135,80M |
| EPS (Diluted) | 7,30 | 1,50 | 2,00 | 2,20 | 1,40 |
| Gross Profit | 482,70M | 915,60M | 799,80M | 772,70M | 674,20M |
| Operating Income | 87,20M | 354,50M | 287,60M | 281,80M | 207,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,85B | 5,99B | 2,90B | 2,78B | 2,39B |
| Total Liabilities | 1,95B | 3,90B | 2,09B | 2,04B | 1,62B |
| Shareholders' Equity | 2,90B | 2,09B | 800,20M | 731,70M | 768,60M |
| Total Debt | 653,30M | 2,42B | 1,06B | 906,10M | 756,30M |
| Cash & Equivalents | 257,40M | 274,70M | 58,40M | 52,60M | 50,60M |
| Current Assets | 1,32B | 1,93B | 1,26B | 1,31B | 980,80M |
| Current Liabilities | 933,70M | 1,22B | 1,08B | 1,12B | 806,30M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#197 of 820
#186 of 658
#40 of 708
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026